Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

724 ARTÍCULOS , VIENDO DEL 526 AL 540

Parkinson's Disease and Voluntary Walking Interventions-A Systematic Review and Meta-analysis

Kloster CT, Bonde-Jensen F, Langeskov-Christensen M, Dalgas U.

Arch Phys Med Rehabil. 2026 Jan 31:S0003-9993(26)00048-1. doi: 10.1016/j.apmr.2026.01.024. Online ahead of print.

Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson's disease

Donadio V, Incensi A, Rizzo G, Furia A, Bonvenga S, Olivola E, Piatti M, Ventruto F, Vacchiano V, Delprete C, Ingelsson M, Modugno N, Postuma R, Cilia R, Liguori R.

Brain. 2026 Mar 5;149(3):856-866. doi: 10.1093/brain/awaf313.

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

Greenland JC, Dresser K, Cutting E, Donegan R, Bond S, Crisp SJ, Scott KM, Voysey ZJ, Holbrook J, Kahanawita L, Pal R, Camacho M, Peattie ARD, Spindler LRB, Hong YT, Fryer TD, Williams-Gray CH.

Lancet Neurol. 2026 Jan;25(1):39-49. doi: 10.1016/S1474-4422(25)00386-2.

Evaluating climbing interventions for Parkinson's disease: a systematic review

Smith RA, Hellman AA.

Front Sports Act Living. 2026 Mar 13;8:1695888. doi: 10.3389/fspor.2026.1695888. eCollection 2026.

Impact of Alcohol Intake on Parkinson's Disease Risk and Progression: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies

Hemeda S, Elmadani M, Merzah M, Odeh A, Pintér E, Balás I, Janszky J, Pintér D, Kovács N.

Mov Disord. 2026 Apr;41(4):843-855. doi: 10.1002/mds.70200. Epub 2026 Jan 24.

A bibliometric analysis of alpha-synuclein in Parkinson's disease from 2015 to 2024

Xiao L, Lin S, Wu Y, Liu X, Gu D, Fan J, Zhuang L.

Front Neurol. 2026 Mar 4;17:1712325. doi: 10.3389/fneur.2026.1712325. eCollection 2026.

Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial

Pahwa R, Moro E, Espay AJ, Evans A, Saint-Hilaire M, Torres-Russotto D, Sanchez R, Leoni M, Duvvuri S, Combs C, Chang I, Tringali S, Boiser J, Zadikoff C, Antonini A.

JAMA Neurol. 2026 May 1;83(5):452-460. doi: 10.1001/jamaneurol.2026.0590.

Foslevodopa-foscarbidopa infusion

Street D, Teare L, Lindahl A, Martin H, Bateman B, Strens L, Samra AP.

Pract Neurol. 2026 May 14;26(3):229-236. doi: 10.1136/pn-2025-004777.

Myoclonus in Pediatric Metabolic Diseases: Clinical Spectrum, Mechanisms, and Treatable Causes-A Systematic Review

Majewska E, Zdort Z, Ochocka A, Paprocka J.

Metabolites. 2026 Jan 28;16(2):98. doi: 10.3390/metabo16020098.

Pearls & Oy-sters: Hereditary Spastic Paraplegia Type 15 Presenting as Juvenile Onset Levodopa-Responsive Parkinsonism

Thatikala A, Boddu AV, Nayar D, Virmani T.

Neurology. 2026 Feb 10;106(3):e214514. doi: 10.1212/WNL.0000000000214514. Epub 2026 Jan 8.

Cannabinoids in Motor Control: From Receptor Distribution to Motor Disorders

Faganeli D, Lipnik-Stangelj M.

Biomedicines. 2026 Apr 8;14(4):844. doi: 10.3390/biomedicines14040844.

Update on spasticity: part 1 - background and diagnosis

Chukwuocha I, Nair KPS.

Drug Ther Bull. 2026 May 11:dtb-2025-000035. doi: 10.1136/dtb.2025.000035. Online ahead of print.

AFG2A-related encephalopathy, expanding the neurodevelopmental and epileptic spectrum

Nou-Fontanet L, Cantalupo G, Braun F, Camacho AR, Álvarez VG, Chilavert VD, Insuga VS, Fernández LA, Alonso-Colmenero I, Arzimanoglou A, Fons C.

Orphanet J Rare Dis. 2026 Apr 3;21(1):128. doi: 10.1186/s13023-026-04204-w.

Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations

Hoskovcova M, Baude M, Biering-Sørensen B, Gal O, Galea MP, Gracies JM, Rodriguez-Blazquez C, Wein T, Tosin MHS, Sánchez-Ferro Á, Mestre TA, Skorvanek M, Jech R; members of the MDS Clinical Outcome Assessments Scientific Evaluation Committee and MDS Spasticity Study Group.

Mov Disord. 2026 Mar 30. doi: 10.1002/mds.70288. Online ahead of print.

SYNCRIP-Related Neurodevelopmental Disorder

Balasubramanian M, Bain JM, Gillentine MA.

2026 May 19. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias